Livedo Reticularis: Causes, Symptoms, and Treatment

What livedo reticularis actually is and where it starts

Livedo reticularis is a visible sign of what's happening in the small blood vessels just beneath your skin. The term describes a reddish-blue to purple, net-like or lacy discoloration that most commonly appears on the legs, though it can show up on the arms, trunk, or other areas. The pattern isn't random. It follows the architecture of the dermal blood vessels, specifically the capillaries and venules that form a branching network under the skin's surface.

The discoloration occurs when blood flow through these tiny vessels slows or becomes obstructed. When oxygen delivery drops, the blood in those vessels becomes deoxygenated, turning darker and creating the characteristic bluish-purple hue. The pale areas in between represent zones where blood flow remains relatively intact. This creates the mottled, reticulated appearance that defines the condition.

The livedo reticularis rash is not a disease in itself. It's a physical sign that something is affecting the microcirculation. That "something" can be as benign as a temporary response to cold or as significant as an autoimmune disorder disrupting blood vessel function. The key distinction lies in whether the pattern is transient or persistent, and whether it occurs in isolation or alongside other symptoms.

How blood flow disruption creates the visible pattern

The visible pattern emerges from a disruption in the normal flow of blood through the skin's microvascular network. Under normal conditions, blood moves smoothly through arterioles, capillaries, and venules, delivering oxygen and nutrients while removing waste. When that flow is impaired, blood pools in the venules and capillaries, becoming deoxygenated and visible through the skin as a dusky, net-like pattern.

Several mechanisms can trigger this disruption:

1. Vasospasm causes temporary constriction of small arteries in response to cold, reducing blood flow to capillary beds and causing blood to pool and deoxygenate.
2. Inflammation of blood vessel walls (vasculitis) impairs normal circulation and creates persistent discoloration.
3. Obstruction by clots or emboli blocks flow through dermal vessels, preventing adequate oxygen delivery.
4. Increased blood viscosity slows circulation through the microvascular network.
5. Structural changes in vessel walls alter their ability to regulate blood flow effectively.

In primary livedo reticularis, vasospasm is the typical driver. This form is common in young women and is considered physiologic, not pathologic. Once the skin warms, the vessels relax, flow resumes, and the pattern fades. In secondary forms, the disruption is more persistent and reflects an underlying pathology. The pattern doesn't resolve with warming and may be accompanied by other signs such as pain, ulceration, or systemic symptoms.

The internal systems connected to this skin pattern

Autoimmune and inflammatory pathways

The pattern is frequently seen in autoimmune conditions where the immune system targets the body's own tissues, including blood vessels. In systemic lupus erythematosus (SLE), immune complexes deposit in vessel walls, triggering inflammation and reducing blood flow. In antiphospholipid syndrome (APS), antibodies against phospholipids promote clot formation in small vessels. This pattern is present in up to 70% of SLE patients who also have APS. Vasculitis, a group of disorders characterized by blood vessel inflammation, can also produce this skin manifestation as part of its clinical presentation.

Coagulation and clotting disorders

Conditions that increase the tendency to form blood clots can manifest as visible skin changes. Antiphospholipid syndrome is the most common culprit, but other hypercoagulable states, including inherited thrombophilias and elevated lipoprotein(a), can also contribute. When small clots form in the dermal vessels, they obstruct flow and create the characteristic mottled pattern. In some cases, this is accompanied by painful skin ulcers or necrosis, particularly in livedoid vasculopathy, a related condition where recurrent thrombosis in the skin leads to scarring and atrophy.

Vascular structure and tone

The integrity and responsiveness of blood vessel walls play a central role. In Sneddon syndrome, a progressive arteriopathy, the skin pattern is paired with recurrent strokes due to widespread vascular damage. In conditions like polyarteritis nodosa, medium-sized arteries become inflamed and narrowed, reducing blood flow to the skin and other organs. Even in the absence of overt disease, abnormal vascular tone, such as exaggerated vasospasm in response to cold or stress, can produce a persistent pattern.

What triggers flares and determines severity

In primary forms, cold exposure is the most common trigger. When skin temperature drops, the body prioritizes blood flow to vital organs by constricting peripheral blood vessels. This physiologic response can produce a transient pattern that resolves with rewarming. Stress and certain medications, particularly vasoconstrictors, can also provoke or worsen the appearance by affecting vascular tone.

In secondary forms, the triggers are more complex and tied to the underlying condition:

• Autoimmune flares increase inflammation and worsen vascular dysfunction.
• Infections can trigger immune-mediated vascular changes or direct endothelial damage.
• Medication changes, particularly those affecting coagulation or vascular tone, influence severity.
• Smoking impairs microvascular function and increases the risk of clot formation.
• Hormonal fluctuations during menstrual cycles or pregnancy alter vascular tone and coagulation factors.

Medications such as beta-blockers, which reduce peripheral blood flow, and certain chemotherapy agents, which can damage blood vessels, have also been implicated in triggering or exacerbating the condition.

Why the same pattern looks different in different people

Not everyone experiences this condition the same way. In some individuals, the pattern is faint and only visible after cold exposure. In others, it's persistent, deeply pigmented, and accompanied by pain or ulceration. These differences reflect variation in the underlying cause, the extent of vascular involvement, and individual factors such as skin tone, vascular anatomy, and immune response.

Skin phototype influences how visible the pattern is. In individuals with lighter skin, the contrast between the deoxygenated blood and surrounding tissue is more pronounced. In those with darker skin, the pattern may be subtler and harder to detect clinically, though the underlying vascular disruption is the same. This can lead to underdiagnosis in certain populations.

Genetic factors also contribute. Inherited thrombophilias, such as Factor V Leiden or prothrombin gene mutations, increase the risk of clot formation. Variants in genes related to vascular tone and endothelial function may influence whether someone develops primary forms in response to cold. Additionally, the presence of other conditions, such as Raynaud's phenomenon or chronic venous insufficiency, can modify the presentation and severity.

The duration and intensity of the underlying trigger matter as well. A brief exposure to cold may produce a transient, mild pattern, while chronic inflammation or repeated microthrombi can lead to persistent, severe changes with complications such as ulceration and scarring. Individual differences in pain perception and skin sensitivity also affect how bothersome the condition feels, even when the visible pattern is similar.

When the pattern points to something systemic

Persistent discoloration, especially when it doesn't resolve with warming or is accompanied by other symptoms, warrants investigation for systemic disease. The most common associations include autoimmune conditions, clotting disorders, and vasculitis. In antiphospholipid syndrome, the skin pattern is often the presenting sign, appearing years before other manifestations such as recurrent miscarriage or thrombosis. In systemic lupus erythematosus, its presence increases the likelihood of concurrent APS and suggests a higher risk of vascular complications.

The pattern can also signal cardiovascular disease. In Sneddon syndrome, the combination of skin changes and stroke reflects widespread arteriopathy affecting both the skin and brain. Some studies have found an association with increased cardiovascular risk, particularly in individuals with other metabolic or inflammatory markers. In rare cases, it has been reported in association with malignancies, including lymphoma and leukemia, where it may reflect paraneoplastic vasculopathy or hypercoagulability.

Infectious triggers are another consideration. Certain viral and bacterial infections can produce transient patterns through immune-mediated vascular inflammation or direct endothelial damage. COVID-19, for example, has been associated with a range of vascular skin manifestations, likely due to endothelial dysfunction and microthrombi formation. In these cases, the pattern typically resolves as the infection clears, but persistent changes may indicate ongoing vascular injury.

When accompanied by ulceration, pain, or systemic symptoms such as fever, weight loss, or joint pain, the likelihood of an underlying systemic condition increases significantly. These cases require a thorough workup, including laboratory testing for autoimmune markers, coagulation studies, and imaging to assess for vascular or organ involvement.

What testing can surface when the pattern keeps coming back

When the discoloration is persistent, painful, or associated with other symptoms, laboratory testing can help identify the underlying driver. The workup typically begins with markers of inflammation and autoimmunity. High-sensitivity C-reactive protein (hs-CRP) and erythrocyte sedimentation rate (ESR) provide a general sense of systemic inflammation. Elevated levels suggest an active inflammatory or autoimmune process that may be affecting the blood vessels.

Autoimmune screening is essential in cases where secondary forms are suspected:

• An antinuclear antibody (ANA) test can flag conditions like lupus.
• Anti-dsDNA and anti-Smith antibodies help confirm lupus diagnosis.
• Anticardiolipin antibodies, anti-beta-2 glycoprotein I antibodies, and lupus anticoagulant identify antiphospholipid syndrome.
• Repeat testing after 12 weeks confirms persistent positivity, as transient elevations can occur with infections.

Coagulation studies are critical when a clotting disorder is suspected. A complete blood count can reveal thrombocytopenia or polycythemia, both of which can contribute to abnormal blood flow. Testing for inherited thrombophilias, such as Factor V Leiden, prothrombin gene mutation, and deficiencies in protein C, protein S, or antithrombin, may be indicated in younger individuals or those with a personal or family history of clotting events. Lipoprotein(a), an independent risk factor for thrombosis, is also worth measuring in cases of unexplained vascular events.

In some cases, a skin biopsy is performed to assess the blood vessels directly. Histopathology can reveal vasculitis, thrombosis, or other structural changes that clarify the diagnosis. Imaging studies, such as Doppler ultrasound or angiography, may be used to evaluate for larger vessel involvement or to assess blood flow in affected areas. When the skin pattern is part of a broader pattern of systemic symptoms, additional testing for metabolic, infectious, or malignant causes may be warranted.

Turning skin symptoms into a systemic investigation

Livedo reticularis treatment depends entirely on the underlying cause. For primary forms, no medical intervention is typically needed. Avoiding cold exposure, wearing warm clothing, and managing stress are usually sufficient. In cases where the pattern is bothersome for cosmetic reasons, vasodilator therapy has been tried, though evidence for its effectiveness is limited.

For secondary forms, treatment targets the underlying condition. In autoimmune diseases such as lupus or APS, immunosuppressive therapy and anticoagulation are the mainstays of management. Antiplatelet agents such as aspirin or anticoagulants such as warfarin or direct oral anticoagulants (DOACs) are used to reduce the risk of complications such as stroke or ulceration. In vasculitis, corticosteroids and other immunosuppressive agents are used to control inflammation and preserve vascular function.

When the condition is associated with ulceration, as in livedoid vasculopathy, wound care becomes a priority. Compression therapy, when appropriate, can improve venous return and reduce pooling. Smoking cessation is critical, as tobacco use significantly impairs healing and worsens vascular function. In refractory cases, treatments such as intravenous immunoglobulin, hyperbaric oxygen therapy, or tissue plasminogen activator have been reported to improve outcomes, though more research is needed to establish their role in routine care.

Mild livedo reticularis in otherwise healthy individuals typically requires no treatment beyond reassurance and lifestyle modifications. However, when the pattern is persistent, progressive, or accompanied by systemic symptoms, a thorough investigation is warranted. Tracking relevant biomarkers over time, not just reacting to individual flares, is more likely to identify the underlying driver and guide effective management.

If your skin pattern doesn't fade with warming, or if it's accompanied by pain, ulcers, or other unexplained symptoms, Superpower's 100+ biomarker panel can help surface what's happening beneath the skin. From inflammatory markers to autoimmune screening to clotting risk factors, the panel provides a systemic view that connects visible skin changes to internal health. When a skin pattern persists, the answer isn't always on the surface. Superpower helps you look deeper, so your next step is informed by data, not guesswork.